Adherence to Combination Therapy in AIDS Clinical Trials (1997)
Chesney, M., Ickovics J., for the Recruitment, Adherence and Retention Committee of the ACTG (1997). Presented at the Annual Meeting of the AIDS Clinical Trials Group, July 1997,Washington, D.C.The Recruitment, Adherence and Retention Subcommittee of the AIDS Clinical Trials Group administered two questionnaires to 76 patients on combination therapy from 10 clinic AIDS Clinical Trials Units during May and June of 1997 (results were presented at the July, 1997 ACTG meeting by Drs.
Instrument: HIV treatment adherence self-efficacy scale Scoring: Included in article Reliability or validity: Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007 Jun 23.
Traditionally, responsibility for providing care in the home for people with serious illness has fallen to women as wives, mothers, or daughters of the afflicted individual. Among the many societal repercussions of the HIV/AIDS epidemic has been the creation of a new group of caregivers—gay men who are the primary caregivers for their partners with AIDS. In the 1980s and early 1990s, before the advent of protease inhibitors and the new antiretroviral treatments, AIDS was a pernicious, essentially uncontrollable terminal illness that manifested horrendous opportunistic infections.
HIV+ persons confront a unique set of challenges and chronic stressors, including stigmatization, alienation from family and friends, complex treatment regimens, and, often, debilitating side effects as they attempt to manage the psychologic and physiological consequences of their condition. For persons living with HIV, elevated distress and low social support take on added importance because they can accelerate disease progression. Helping HIV+ people to reduce stress and adhere to their medical care may in turn help to reduce their risky behavior.
The National Institutes of Health’s Fogarty International Center in collaboration with a number of other agencies sponsored the Fogarty Workshop on International HIV/AIDS Prevention Research Opportunities on April 18-20, 1998. The AIDS Research Institute at the University of California, San Francisco hosted the Workshop. The purpose of the workshop was to identify a package of effective HIV prevention interventions and develop a list of priority research goals that combine biomedical, behavioral and social interventions for HIV prevention in developing countries.